Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

2471-2480 of 4090 results

Catalogue Number:

PX-TA2049

Category:

G

Proteo Genix logo

Belrestotug Biosimilar – Anti-VSTM3 mAb – Research Grade

Target: VSTM3
Target Alias Name: anti-VSTM3/ TIGIT/ V-set and transmembrane domain-containing protein 3/ VSIG9/ V-set and immunoglobulin domain-containing protein 9/ T-cell immunoreceptor with Ig and ITIM domains
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1797

Category:

G

Proteo Genix logo

Beludavimab Biosimilar – Anti-Spike RBD mAb – Research Grade

Target: Spike RBD
Target Alias Name: Beludavimab/GSK4182137/ VIR-7832/ WBP2271/Spike RBD/anti-Spike RBD
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1492

Category:

G

Proteo Genix logo

Bemarituzumab Biosimilar – Anti-FGFR2 mAb – Research Grade

Target: FGFR2
Target Alias Name: Bemarituzumab/FPA-144/FPA114-A/FGFR2/anti-FGFR2
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA2052

Category:

G

Proteo Genix logo

Bempikibart Biosimilar – Anti-IL7R mAb – Research Grade

Target: IL7R
Target Alias Name: anti-IL7R/ Interleukin-7 receptor subunit alpha/ IL-7R-alpha/ IL-7 receptor subunit alpha/ CD127/ CDw127/ IL-7R subunit alpha/ IL-7RA
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1938

Category:

G

Proteo Genix logo

Benmelstobart Biosimilar – Anti-B7-H1 mAb – Research Grade

Target: B7-H1
Target Alias Name: anti-B7-H1/ Programmed cell death 1 ligand 1/ PDCD1 ligand 1/ PDCD1L1/ B7 homolog 1/ PDCD1LG1/ PDL1/ hPD-L1/ Programmed death ligand 1/ B7H1/ PD-L1/ CD274
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1240

Category:

G

Proteo Genix logo

Benralizumab Biosimilar – Anti-IL5RA/ CD125 mAb – Research Grade

Target: IL5RA/ CD125
Target Alias Name: Benralizumab/BIW-8405/KHK4563/MEDI-563/IL5RA/ CD125/anti-IL5RA/ CD125
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1814

Category:

G

Proteo Genix logo

Bentracimab Biosimilar – Anti-AR-C124910XX mAb – Research Grade

Target: AR-C124910XX
Target Alias Name: Bentracimab//AR-C124910XX/anti-AR-C124910XX
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1 Lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1583

Category:

G

Proteo Genix logo

Benufutamab Biosimilar – Anti-TNFRSF10B/ TRAILR2/ CD262 mAb – Research Grade

Target: TNFRSF10B/ TRAILR2/ CD262
Target Alias Name: Benufutamab /GEN1029/TNFRSF10B/ TRAILR2/ CD262/anti-TNFRSF10B/ TRAILR2/ CD262
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1815

Category:

G

Proteo Genix logo

Bepranemab Biosimilar – Anti-MAPT mAb – Research Grade

Target: MAPT
Target Alias Name: Bepranemab//MAPT/anti-MAPT
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4 Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1486

Category:

G

Proteo Genix logo

Berlimatoxumab Biosimilar – Anti-LukGH mAb – Research Grade

Target: LukGH
Target Alias Name: Berlimatoxumab/ASN-100 (combination of atidortoxumab and berlimatoxumab)/ASN-2/LukGH/anti-LukGH
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo